Contributor:

and Savak “Sev” Teymoorian, MD, MBA

Achieving Success in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

iDose TR Postoperative Success

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Outcomes

Savak “Sev” Teymoorian, MD, MBA

Making Patients Comfortable With iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR & Interventional Glaucoma

Savak “Sev” Teymoorian, MD, MBA

iDose TR: An Interventional Mindset

Savak “Sev” Teymoorian, MD, MBA

iDose TR Patient Selection

Savak “Sev” Teymoorian, MD, MBA

iDose TR: A Patient’s Perspective

Savak “Sev” Teymoorian, MD, MBA

iDose TR: Day of Procedure

Savak “Sev” Teymoorian, MD, MBA

Incorporating iDose TR

Savak “Sev” Teymoorian, MD, MBA

Patient Education for iDose TR

Savak “Sev” Teymoorian, MD, MBA

An Interview With an iDose TR Retreatment Patient

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

iDose TR® Live Retreatment Procedures on Demand

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

Addressing the Medication Burden: Procedural Options and the IG Consensus Treatment Protocol

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

Case Presentation: A Straightforward iDose TR Exchange

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

Case Presentation: Navigating iDose TR Retreatment in a Patient Four Years Later

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

Building Trust and Managing Patient Expectations With iDose TR

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA